Mesoblast earnings beat by $0.01, revenue topped estimates
Investing.com - Mesoblast (NASDAQ: MESO) reported second quarter EPS of $-0.166, $0.01 better than the analyst estimate of $-0.180. Revenue for the quarter came in at $2.13M versus the...
Neutral
or
Mesoblast News & Analysis
-
-
Mesoblast Announces DREAM-HF Phase 3 Trial Results for Cell Therapy in Heart Failure Published in JACC
Mesoblast (NASDAQ:MESO) Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced publication of the DREAM-HF Phase 3 trial...
-
Mesoblast earnings beat, Revenue misses in Q1
Investing.com - Mesoblast reported on Tuesday first quarter {{erl-942042||earnings that beat analysts' forecasts and revenue that fell short of expectations. Mesoblast announced earnings...
-
Mesoblast earnings beat, Revenue misses in Q4
Investing.com - Mesoblast reported on Tuesday fourth quarter {{erl-942042||earnings that beat analysts' forecasts and revenue that fell short of expectations. Mesoblast announced earnings...
-
Mesoblast earnings, Revenue miss in Q3
Investing.com - Mesoblast reported on Thursday third quarter {{erl-942042||earnings that missed analysts' forecasts and revenue that fell short of expectations. Mesoblast announced...
-
Mesoblast earnings, Revenue beat in Q2
Investing.com - Mesoblast reported on Thursday second quarter {{erl-942042||earnings that beat analysts' forecasts and revenue that topped expectations. Mesoblast announced earnings per...
-
Mesoblast earnings, Revenue miss in Q1
Investing.com - Mesoblast reported on Thursday first quarter {{erl-942042||earnings that missed analysts' forecasts and revenue that fell short of expectations. Mesoblast announced...
-
Mesoblast earnings, Revenue miss in Q4
Investing.com - Mesoblast reported on Monday fourth quarter {{erl-942042||earnings that missed analysts' forecasts and revenue that fell short of expectations. Mesoblast announced earnings...
-
Mesoblast earnings, Revenue miss in Q4
Investing.com - Mesoblast reported on Wednesday fourth quarter {{erl-942042||earnings that missed analysts' forecasts and revenue that fell short of expectations. Mesoblast announced...
-
Mesoblast earnings, Revenue miss in Q2
Investing.com - Mesoblast reported on Friday second quarter {{erl-942042||earnings that missed analysts' forecasts and revenue that fell short of expectations. Mesoblast announced earnings...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.41%
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Oil & Gas, Utilities and Financials sectors propelled shares lower. At the close in NYSE, the Dow Jones...
-
Mesoblast earnings, Revenue miss in Q1
Investing.com - Mesoblast reported on Thursday first quarter {{erl-942042||earnings that missed analysts' forecasts and revenue that fell short of expectations. Mesoblast announced...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.48%
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Technology, Consumer Services and Consumer Goods sectors propelled shares lower. At the close in NYSE, the...
-
Mesoblast earnings, Revenue miss in Q4
Investing.com - Mesoblast reported on Wednesday fourth quarter {{erl-942042||earnings that missed analysts' forecasts and revenue that fell short of expectations. Mesoblast announced...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.12%
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Oil & Gas, Telecoms and Financials sectors propelled shares higher while losses in the Utilities, Healthcare...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.38%
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Utilities, Technology and Healthcare sectors propelled shares lower. At the close in NYSE, the Dow Jones...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.51%
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Financials, Basic Materials and Industrials sectors propelled shares higher. At the close in NYSE, the Dow...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.11%
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Technology, Basic Materials and Healthcare sectors propelled shares higher. At the close in NYSE, the Dow...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.33%
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Financials, Basic Materials and Consumer Services sectors propelled shares lower. At the close in NYSE,...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
